HER2/neu over-expression induces endothelial cell retraction

Clinical significance of Syk expression in human esophageal squamous cell carcinoma

AIM: To investigate the expression of spleen tyrosine kinase (Syk) mRNA and protein in human esophageal squamous cell carcinoma (ESCC) and analyze its correlation with the malignant biological behavior of ESCC.

METHODS: The expression of Syk protein in 48 ESCC specimens and matched adjacent non-carcinoma specimens was detected by immunohistochemistry. The expression of Syk mRNA in 43 ESCC specimens and matched adjacent non-carcinoma specimens was assayed by reverse transcription-polymerase chain reaction (RT-PCR). The correlations of Syk expression with tumor size, TNM stage and lymph node metastasis were analyzed.

RESULTS: The positive rate of Syk protein expression in ESCC tissue was significantly lower than that in adjacent non-carcinoma tissue (16.67% vs 89.58%, P < 0.05). The expression of Syk protein was correlated with tumor TNM stage in ESCC (χ² = 6.713, P < 0.05). A significant difference was noted in Syk expression between ESCC with and without lymph node metastasis (3.03% vs 29.41%, P < 0.05). No significant correlation was observed between Syk expression and tumor size (χ² = 0.017, P > 0.05). RT-PCR analysis showed that the expression level of Syk mRNA was significantly lower in ESCC than in adjacent non-carcinoma tissue (t = -11.27, P < 0.05).

CONCLUSION: Downregulation of Syk gene expression may be involved in the carcinogenesis and metastasis of ESCC. Syk gene is a novel candidate tumor suppressor gene in ESCC and can be used as a molecular marker for early diagnosis and treatment of ESCC.